Cancer
Researchers at Columbia University Irving Medical Center have made a significant advancement in cancer gene therapy by developing a multiplex base editing approach. This innovative method involves editing the CD33 gene to protect myeloid progeny from cancer therapies while preserving normal hematopoiesis. The study demonstrates the potential for improved immunotherapies
Cancer
Researchers have made significant progress in developing mRNA therapy as a promising approach in oncology, offering innovative applications such as tumor vaccines, protein replacement therapy, cell therapy, and gene therapy. However, challenges such as mRNA stability and delivery efficiency must be addressed for effective treatment. A recent review outlined the
Genetic research
Research published by the Institute of Applied Biosciences reveals a crucial link between antigen selection and the development of splenic marginal zone lymphoma (SMZL). The study found that almost one-third of all SMZL cases express B-cell receptor immunoglobulin (BcR IG) encoded by the IGHV1-2*04 gene, suggesting that antigen selection
Genetic research
Researchers at the Shengjing Hospital of China Medical University have conducted a study on pediatric acute lymphoblastic leukemia (ALL), a common blood cancer in children. Despite a high cure rate of 90%, relapse still occurs in a subset of patients. The study aimed to investigate the molecular characteristics and prognostic
Genetic research
A recent study published in Frontiers in Oncology has shed light on the significant role of the MYEOV gene in various types of cancers, including multiple myeloma, breast cancer, lung cancer, pancreatic cancer, and esophageal cancer. The research highlights the gene's high expression levels in malignant tumors and
Cancer
Researchers have made significant progress in developing mRNA therapy as a promising approach in oncology, offering innovative applications such as tumor vaccines, protein replacement therapy, cell therapy, and gene therapy. However, challenges such as mRNA stability and delivery efficiency must be addressed for effective treatment. A recent review outlined the
Cancer research
Researchers at Jilin University have developed a novel ER-targeted PEGylated liposome (ES-SSL-PTX/CDDP) coencapsulating paclitaxel (PTX) and cisplatin (CDDP) to enhance therapeutic efficacy and mitigate systemic toxicity in the treatment of ovarian cancer. The research demonstrates the potential of this targeted delivery system to improve the efficacy and reduce the
Cancer research
Fresh data on prostate cancer research reveal that the RNA editing gene APOBEC3C has been identified as a potential candidate tumor suppressor. According to a study published in the journal Scientific Reports, the researchers investigated the role of APOBEC3C in prostate cancer (PCa) and found that it exhibits significant positive
Cancer
The US Food and Drug Administration (FDA) has granted accelerated approval to afamitresgene autoleucel, a melanoma-associated antigen-A4 (MAGE-A4)-directed genetically modified autologous T-cell immunotherapy, for the treatment of adults with unresectable or metastatic synovial sarcoma (SS) who have received prior chemotherapy. This approval represents a major breakthrough in the treatment
Cancer research
Researchers from King Faisal University in Saudi Arabia have made a significant discovery in the field of cancer gene therapy, specifically in the treatment of hepatocellular carcinoma (HCC). According to a recent study published in Pharmaceutics, the team has found that combining nanotechnology with natural products has emerged as a
Cancer research
A recent study from Zhejiang University has shed new light on the potential of gut bacteria in cancer treatment, revealing their remarkable anticancer properties and diverse mechanisms of action against tumor cells. The research, published in Microbiology Research in 2025, discusses the utilization of gut bacteria as therapeutic agents against
Cancer research
A team of researchers at Cincinnati Children's Hospital Medical Center has made significant progress in cancer gene therapy, as revealed in a new study published in Molecular Therapy: Methods & Clinical Development. The research, focused on sickle cell anemia, demonstrates the efficacy of a modified gamma-globin lentivirus gene
